BPTH

Bio-Path Holdings (BPTH)

About Bio-Path Holdings (BPTH)

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

Details

Daily high

$1.16

Daily low

$1.09

Price at open

$1.15

52 Week High

$16.00

52 Week Low

$0.85

Market cap

2.9M

Dividend yield

0.00%

Volume

243,257

Avg. volume

3.5M

P/E ratio

-.06

Bio-Path Holdings News